“…Compared to oxylipins derived from n–3 PUFAs (DHA, EPA), those derived from n–6 PUFAs (AA, LA) generally, but not always, exhibit pro-inflammatory, vasoconstrictive, and proliferative effects ( Gabbs et al, 2015 ). In the acute phase of ICH, the increased production of LTE4, PGJ2, 5-oxo-ETE, and 15-oxo-ETE derived from AA may exhibit vasoconstrictive, pro-apoptotic, pro-inflammatory, and chemoattractant effects which are inclined to aggregate the damage of ICH, while 5,6-DiHETrE, 12-HETE, and EETs show opposing effects such as vasodilative, anti-apoptotic, or anti-inflammatory activities ( Sudhahar et al, 2010 ; Bennett and Gilroy, 2016 ; Figueiredo-Pereira et al, 2016 ; Shearer and Walker, 2018 ; Rahman et al, 2019 ; Wójcik et al, 2020 ). Of note, these oxylipins of AA change with the progression of ICH and the destructive oxylipins appear to peak 3 days after ICH when the protective oxylipins of AA have descended suggesting that AA-derived oxylipins tend to cause damage with the development of ICH.…”